High-risk human papillomavirus reduces the expression of microrna-218 in women with cervical intraepithelial neoplasia

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1730-1736

  Li, Y ^a   Liu, J ^a   Yuan, C ^a   Cui, B ^a   Zou, X ^a   Qiao, Y ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Genotype; Human papillomavirus(HPV); MIR 218

Indexed keywords

MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PATHOGENESIS; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VERRUCA VULGARIS;

EID: 78449310086     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800518     Document Type: Article

References (37)

1. World Health Organization: Initiative for Vaccine Research. Human Papillomavirus. Geneva: WHO, 2007 (available at: http://www.whoint/vaccine_research/diseases/viral_cancers/en/ind ex3html).
2. Walboomers J, Jacobs M, Manos M, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
3. Munoz N, Bosch FX, de Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
5. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
6. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
7. Kim VN: Small RNAs: classification, biogenesis, and function. Mol Cells 2005; 19: 1-15.
8. Calin GA, Liu CG, Sevignani C, et al: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004; 101: 11755-11760.
9. Iorio MV, Casalini P, Tagliabue E, et al: MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 2008; 44: 2753-2759.
10. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-3756.
11. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
12. Yan D, Zhou X, Chen X, et al: MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009; 50: 1559-1565.
13. Su H, Yang JR Xu T, et al: MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009; 69: 1135-1142.
14. Martinez I, Gardiner AS, Board KF, et al: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008; 27: 2575-2582.
15. Culp TD, Budgeon LR, Marinkovich MP, et al: Keratinocyte-secreted laminin 5 can function as a transient receptor for human apillomaviruses by binding virions and transferring them to adjacent cells. J Virol 2006; 80: 8940-8950.
16. Grisaru D, Avidor B, Niv J, et al: Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination. J Clin Microbiol 2008; 46: 1602-1605.
17. Carozzi F, Bisanzi S, Sani C, et al: Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease. J Clin Microbiol 2007; 45: 364-369.
18. Varkonyi-Gasic E, Wu R, Wood M, et al: Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 2007; 3: 12.
19. -δδCT method. Methods 2001; 25: 402-408.
20. Zhu X, Han T, Sargent I, et al: Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 2009; 200: 661.e1-61.e7.
21. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
22. Ruvkun G: Molecular biology. Glimpses of a tiny RNA world. Science 2001; 294: 797-799.
23. Lagos-Quintana M, Rauhut R, Lendeckel W, et al: Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858.
24. Lau NC, Lim LP, Weinstein EG, et al: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294: 858-862.
25. Lee RC, Ambros V: An extensive class of small RNAs in Caenorhabditis elegans. Science 2001;294: 862-864.
26. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
27. Meng F, Henson R, Lang M, et al: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangio-carcinoma cell lines. Gastroenterology 2006; 130: 2113-2129.
28. Li Y, Li W, Yang Y, et al: MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 2009; 1286:13-18.
29. Gao C, Zhang Z, Liu W, et al: Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41-49.
30. Liu W, Gong YH, Chao TF, et al: Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chin Med J (Engl) 2009; 122: 2405-2411.
31. Schembri F, Sridhar S, Perdomo C, et al: MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 2009; 106:2319-2324.
32. Scheffner M, Huibregtse J, Vierstra R, et al: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-505.
33. Xi Y, Shalgi R, Fodstad O, et al: Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006; 12:2014-2024.
34. Singh RK, Indra D, Mitra S, et al: Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Hum Genet 2007; 122: 71-81.
35. Skyldberg B, Salo S, Eriksson E, et al: Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999; 91: 1882-1887.
36. Dajee M, Lazarov M, Zhang JY, et al: NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003;421:639-643.
37. Calaluce R, Bearss DJ, Barrera J, et al: Laminin-5 β3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 2004; 6: 468-479.